Molecular Templates to Present at Upcoming Investor Conferences

AUSTIN, Texas, May 17, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), will participate in the following upcoming investor conferences.

Details can be found below:

H.C. Wainwright Global Investment Conference (May 23-26, 2022)
Location: Virtual

Company Presentation

Tuesday, May 24th
Time: 7:00 AM ET
Jefferies Healthcare Conference (June 8-10, 2022)
Location: Marriott Marquis in New York, New York

Fireside Chat

Thursday, June 9th
Time: 2:00 PM – 2:25 PM ET

Webcast links for the presentations will be posted on the “News & Media” section of the Molecular Templates corporate website, under Events.

About Molecular Templates
Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Our proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases.

Investor Contact:
Joyce Allaire
LifeSci Advisors, LLC

Source: Molecular Templates, Inc.

Primary Logo

Source: Molecular Templates, Inc.